Filter
1570
Text search:
Rapid
Diagnostics
Featured
Recommendations
209
New Publications
376
Language
Document type
No document type
707
Studies & Reports
338
Guidelines
262
Strategic & Response Plan
98
Manuals
90
Fact sheets
35
Situation Updates
13
Training Material
12
Infographics
6
Online Courses
5
Brochures
2
Resource Platforms
2
Countries / Regions
Global
90
India
70
Western and Central Europe
36
Kenya
34
Africa
34
Eastern Europe
26
Malawi
25
Ukraine
25
Sierra Leone
24
Ethiopia
24
Zambia
24
Tanzania
23
Liberia
22
Uganda
22
Nigeria
21
Latin America and the Carribbean
21
Nepal
20
West and Central Africa
20
South Africa
19
East and Southern Africa
19
Asia
18
Russia
17
Bangladesh
14
Myanmar / Burma
14
South–East Asia Region
14
Ghana
12
Rwanda
12
Namibia
11
Brazil
11
Congo, Democratic Republic of
10
Guinea
9
Philippines
8
Germany
8
Syria
8
Middle East and North Africa
8
Zimbabwe
7
Cambodia
7
Lesotho
6
Pakistan
5
Mozambique
5
Eastern Europe and Central Asia
5
Senegal
4
Benin
4
Argentina
4
Peru
4
Colombia
4
Botswana
4
Western Pacific Region
4
Moldova
4
Burkina Faso
3
USA
3
Cameroon
3
South Sudan
3
China
3
Indonesia
3
Eswatini/ Swaziland
3
Georgia
3
North America
3
Haiti
2
Jordan
2
Afghanistan
2
Lebanon
2
Sudan
2
Central African Republic
2
North Macedonia
2
Ecuador
2
Sri Lanka
2
Yemen
2
Bhutan
2
Albania
2
Laos
2
Timor Leste/ East Timor
2
Bulgaria
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Somalia
1
Iraq
1
Thailand
1
Papua New Guinea
1
Hungary
1
Burundi
1
Bolivia
1
Greece
1
Angola
1
Madagascar
1
Chile
1
Other region
1
Fiji
1
Venezuela
1
Poland
1
North Korea
1
Armenia
1
Mongolia
1
Tajikistan
1
Romania
1
Lithuania
1
Slovakia
1
Iran
1
Kazakhstan
1
Vietnam
1
Turkmenistan
1
Jamaica
1
Denmark
1
Tunisia
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
486
Clinical Guidelines
168
Public Health
73
Pharmacy & Technologies
66
Key Resources
46
Women & Child Health
25
Capacity Building
14
Toolboxes
TB
262
COVID-19
197
HIV
194
NTDs
92
AMR
79
Malaria
48
Rapid Response
43
Ebola & Marburg
39
Planetary Health
32
Health Financing Toolbox
31
2.0 Rapid Response
27
Zika
24
NCDs
22
Pharmacy
19
Conflict
17
Mental Health
16
Global Health Education
16
Refugee
15
Cholera
13
Caregiver
11
Polio
9
Natural Hazards
6
Disability
4
Specific Hazards
3
This document is an evidence-based policy for the implementation of sound tuberculosis (TB) infection control by all stake- holders. It recommends a combination of measures aimed at reducing the risk of TB transmission within populations. The emphasis is on early and
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the
...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi
...
The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats. Genomic surveillance is part of the broader surveillance and laboratory system, a
...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var
...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as
...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diag
...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemicINTERIM GUIDANCE5 February2021
The Community needs, perceptions and demand: community assessment toolcan be used by countries to conduct a rapid p
...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid ant
...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource setting
...
Household transmission investigation protocol for 2019-novel coronavirus (2019-nCoV) infection
recommended
The household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-nCoV infection (see 2.2 Study population). It is intended to provide rapid and early information on
...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti
...
HAT diagnosis relies on laboratory techniques because clinical signs and symptoms are unspecific. Serodiagnostic tests exist only for Tbg and are based on the detection of specific antibodies, thus they are not confirmatory of infection. With the current low disease prevalence, the positive predicti
...
Tuberculosis (TB) remains a significant global health challenge, with an estimated annual death rate of approximately one per 100,000 people in countries with low TB prevalence. Rapid reductions in TB cases and deaths worldwide depend on research
...
